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Contributed Podium Presentations
are important tools to monitor and estimate the occurrence 
of ADRs. However, from a public health perspective it is also
important to obtain information on the proportion of the general
population who experience ADRs. This study aims to analyze
the prevalence of subjectively experienced ADRs in the Swedish
population during a two week time period. METHODS: A
postal survey on health, quality of life and use of drugs was done
for a statistical population sample, 20–84 years, in Sweden,
2004/2005. A total of 4875 (61%) answered the questionnaire.
In it, the respondent could name up to three drug treatments with
subjectively experienced ADRs during the immediate two weeks
prior to the completion of the questionnaire. All ADRs reported
were reviewed and classiﬁed according to Meyler’s Side Effects
of Drugs. RESULTS: A total of 2856 (58.6%) reported use of
prescription drugs. Of these users, 10.2% reported having expe-
rienced at least one ADR during the recall period. Prescription
drug use was more common among women (66.6%) than among
men (49.2%) but there were no differences between genders in
the proportion reporting ADRs (10.8% and 9.1%, N.S). Users
aged 18–44 reported ADRs to a greater extent (13.0%) than
users aged 45–64 (9.4%) and users aged 65–84 (8.3%) (p <
0.05). The highest prevalence of subjectively experienced ADRs
was found among antidepressant (16.3%), antibiotics (13.8%)
and analgesics (8.5%) users. Of all users, 5.5% reported nervous
system ADRs; 3.8% and 1.0% reported gastrointestinal and car-
diovascular ADRs, respectively. CONCLUSIONS: A substantial
proportion of users of prescription drugs subjectively experi-
enced ADRs during the period studied. Doctors, pharmacists and
other health care professionals should be observant and thor-
oughly interview the patient about ADRs. Population-based
prevalence studies of ADRs are an important complement to
spontaneous reporting systems.
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OBJECTIVES: To identify determinants of non-compliance with
bisphosphonate therapy in women with post-menopausal osteo-
porosis. METHODS: Data were obtained from the PHARMO
Record Linkage System, which includes linked drug-dispensing
records and hospital records for more than two million individ-
uals in deﬁned areas of The Netherlands. New female users of
alendronate or risedronate in the period 1 January 1999–30 June
2004, aged °Y´ 45 years or with diagnosed post-menopausal
osteoporosis were included in the study. One-year compliance
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OBJECTIVES: Up to 90% of the patients visiting methadone
clinics smoke tobacco. Computer-mediated approaches to
promote smoking cessation in this population have not been
studied systematically. We conducted a pilot study on the feasi-
bility of using tablet PCs for anti-smoking education in a
methadone clinic. METHOD: We asked 35 methadone-treated
patients who smoke to use a smoking hazards education
program installed on a tablet PCs for approximately 40 minutes.
We collected data on their smoking status and administered a
smoking hazards knowledge questionnaire before and after the
intervention. The knowledge questionnaire consisted of 35 basic
statements about smoking with “true” or “false” options as a
response. RESULTS: The sample consisted of 27 women
(77.1%), 8 men; 45.4 ± 6.7 years old. Most of them were unem-
ployed (27 subjects, 77.1%). They smoked for 23.2 ± 10.2 years
and 25 subjects (71.4%) smoked 1 pack a day or more. Accord-
ing to Prochaska’s Stage of Change Scale the majority of the
patients were in precontemplation stage (23 subjects, 65.7%),
the remaining patients were in the preparation or contemplation
stage. Twenty patients (57.1%) discussed their smoking at least
once with their doctors, although it was not connected with their
knowledge about smoking hazards or their stage of change. As
a result of computer-mediated education, their knowledge about
smoking hazards signiﬁcantly increased from 14.2 ± 2.9 points
to 20.1 ± 3.0 points, p < 0.0001. For 27 subjects (77.1%) it was
not complicated at all to use the computer. Most of the patients
(32 persons, 91.4%) rated the program as good or excellent.
CONCLUSION: Tablet PCs were feasible and effective means of
education about smoking hazards and was very well accepted by
the patients. Computer-assisted education may potentially be an
effective health promotion tool for patients seen in methadone
clinics.
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OBJECTIVES: Spontaneous reporting systems where unex-
pected and/or severe adverse drug reactions (ADR) are reported
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